Umoja Biopharma
Umoja Biopharma is a Seattle-based biotech company developing in vivo cancer immunotherapies, employing 240 people and raising $363M in funding. Its Series C round closed in January 2025.
The growth story
Umoja Biopharma grew from 88 to 240 employees between 2021 and 2026, raising $363M along the way, most recently a Series C in January 2025.
About
Umoja Biopharma creates cancer treatments that reprogram a patient’s immune system directly in the body, aiming to avoid the side effects of traditional therapies. Its approach targets the natural immune response to enhance cancer-fighting capabilities.
The company has grown rapidly since its 2019 founding, reaching 240 employees and securing $363M in funding, including a Series C round in early 2025. Its investor base includes prominent firms like ARK Investment Management and Casdin Capital.
Founders and leadership
Research is Umoja’s largest function, accounting for 50 employees. The company’s leadership team is based in Seattle, where it was founded in 2019.
The Umoja Biopharma org chart
Andy Scharenberg (Chief Executive Officer) leads 59 mapped leaders with 5 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 61 (+11% YoY), Operations 38 (+9% YoY), Quality Assurance 28 (+47% YoY), Business Development 23 (+5% YoY), Healthcare Services 9 (+50% YoY), Information Technology 8 (+14% YoY).
Talent flow
Umoja’s workforce draws heavily from Novartis, AGC Biologics, and Juno Therapeutics, with 24, 23, and 19 hires respectively. Alumni often move to Bristol Myers Squibb, Legend Biotech, and BrainChild Bio.
Most common previous employers of Umoja Biopharma staff: Novartis (24), AGC Biologics (23), Juno Therapeutics (19), Amgen (18), University of Washington (15), KBI Biopharma (14). Former Umoja Biopharma employees most often moved to Bristol Myers Squibb (8), Legend Biotech (5), BrainChild Bio (3), HDT Bio (2), KBI Biopharma (2), Pfizer (2).
Alumni worth knowing
The Umoja Biopharma mafia
Umoja alumni have founded three companies, including Zelig Therapeutics, which employs three staff, and Agility PM Consulting.
3Shon Green, was Senior Director, Translational Sciences until 2023April DeCarlo, was Senior Analyst | Enterprise Systems until 2025Nanda Coelho, was Senior Scientist until 2023Hiring now
Web traffic
Traffic mix: 20% direct, 53% search, 18% social, 0% paid.
What this company is made of
Most common skills at Umoja Biopharma: Biotechnology (73), Research Skills (67), Cell Culture (66), Good Manufacturing Practice (GMP) (65), Microsoft Office (57), Leadership (56), Microsoft Excel (54), Data Analysis (53).
Where the team actually sits
Umoja Biopharma people are concentrated in Colorado, United States (69), Washington, United States (53), Denver Metropolitan Area (25), Greater Seattle Area (14).
Search footprint
Umoja Biopharma attracts about 1,260 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 24 ranking keywords and lost 51 in the last period.
What employees say
- Compensation
- 3.90 / 5
- Career opportunities
- 3.80 / 5
- Senior management
- 3.20 / 5
- Work-life balance
- 3.70 / 5
Frequently asked
Umoja Biopharma has 240 employees as of September 2026.
Umoja Biopharma has raised $363M in total, most recently a Series C round in January 2025.
Umoja Biopharma was founded in 2019 by Ryan Crisman, The Late Philip Low.
Andy Scharenberg (Chief Executive Officer) sits at the top of Umoja Biopharma's reporting structure, with 5 direct reports.
The most common previous employers of current Umoja Biopharma staff are Novartis (24 people), AGC Biologics (23 people), Juno Therapeutics (19 people).
Former Umoja Biopharma employees most often move to Bristol Myers Squibb (8), Legend Biotech (5), BrainChild Bio (3).
At least 3 companies have a founder who previously worked at Umoja Biopharma, including Zelig Therapeutics, Agility PM Consulting, https://www.sweetsixteen.com.br/.
Umoja Biopharma attracts about 1,260 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Umoja Biopharma staff are Biotechnology, Research Skills, Cell Culture, Good Manufacturing Practice (GMP), Microsoft Office.
Umoja Biopharma staff are concentrated in Colorado, United States (69), Washington, United States (53), Denver Metropolitan Area (25).
Umoja Biopharma has about 61 people in Research, up 11% over the past year, as of September 2026.
Umoja Biopharma has about 38 people in Operations, up 9% over the past year, as of September 2026.
Computed from 182 current and 116 former Umoja Biopharma profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.